168 related articles for article (PubMed ID: 29958546)
1. Neuroimaging-pathological correlations of [
Ishiki A; Harada R; Kai H; Sato N; Totsune T; Tomita N; Watanuki S; Hiraoka K; Ishikawa Y; Funaki Y; Iwata R; Furumoto S; Tashiro M; Sasano H; Kitamoto T; Kudo Y; Yanai K; Furukawa K; Okamura N; Arai H
Acta Neuropathol Commun; 2018 Jun; 6(1):53. PubMed ID: 29958546
[TBL] [Abstract][Full Text] [Related]
2. 18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
Passamonti L; Vázquez Rodríguez P; Hong YT; Allinson KS; Williamson D; Borchert RJ; Sami S; Cope TE; Bevan-Jones WR; Jones PS; Arnold R; Surendranathan A; Mak E; Su L; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
Brain; 2017 Mar; 140(3):781-791. PubMed ID: 28122879
[TBL] [Abstract][Full Text] [Related]
3. Cerebral Tau Deposition in Comorbid Progressive Supranuclear Palsy and Amyotrophic Lateral Sclerosis: An [18F]-Flortaucipir and 7T MRI Study.
Cheong I; Du Y; Smith G; Hua J; Li X; Pantelyat A
Neurodegener Dis; 2023; 23(3-4):35-42. PubMed ID: 38527450
[TBL] [Abstract][Full Text] [Related]
4. Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.
Cope TE; Rittman T; Borchert RJ; Jones PS; Vatansever D; Allinson K; Passamonti L; Vazquez Rodriguez P; Bevan-Jones WR; O'Brien JT; Rowe JB
Brain; 2018 Feb; 141(2):550-567. PubMed ID: 29293892
[TBL] [Abstract][Full Text] [Related]
5. Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies.
Marquié M; Normandin MD; Meltzer AC; Siao Tick Chong M; Andrea NV; Antón-Fernández A; Klunk WE; Mathis CA; Ikonomovic MD; Debnath M; Bien EA; Vanderburg CR; Costantino I; Makaretz S; DeVos SL; Oakley DH; Gomperts SN; Growdon JH; Domoto-Reilly K; Lucente D; Dickerson BC; Frosch MP; Hyman BT; Johnson KA; Gómez-Isla T
Ann Neurol; 2017 Jan; 81(1):117-128. PubMed ID: 27997036
[TBL] [Abstract][Full Text] [Related]
6. Quantitative evaluation of tau PET tracers
Chen J; Li Y; Pirraglia E; Okamura N; Rusinek H; de Leon MJ;
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1596-1604. PubMed ID: 29704038
[TBL] [Abstract][Full Text] [Related]
7. [
Blazhenets G; Soleimani-Meigooni DN; Thomas W; Mundada N; Brendel M; Vento S; VandeVrede L; Heuer HW; Ljubenkov P; Rojas JC; Chen MK; Amuiri AN; Miller Z; Gorno-Tempini ML; Miller BL; Rosen HJ; Litvan I; Grossman M; Boeve B; Pantelyat A; Tartaglia MC; Irwin DJ; Dickerson BC; Baker SL; Boxer AL; Rabinovici GD; La Joie R
J Nucl Med; 2023 Dec; 64(12):1980-1989. PubMed ID: 37918868
[TBL] [Abstract][Full Text] [Related]
8. Detailed Assessment of 18F-THK5351 Distribution Pattern in the Midbrain: Comparison With Progressive Supranuclear Palsy and Corticobasal Syndrome.
Ishibashi K; Kurihara M; Ihara R; Higashihara M; Iwata A; Ishii K
Clin Nucl Med; 2023 Oct; 48(10):841-846. PubMed ID: 37682599
[TBL] [Abstract][Full Text] [Related]
9. In Vivo
Malpetti M; Kaalund SS; Tsvetanov KA; Rittman T; Briggs M; Allinson KSJ; Passamonti L; Holland N; Jones PS; Fryer TD; Hong YT; Kouli A; Bevan-Jones WR; Mak E; Savulich G; Spillantini MG; Aigbirhio FI; Williams-Gray CH; O'Brien JT; Rowe JB
J Nucl Med; 2022 Jul; 63(7):1052-1057. PubMed ID: 34795013
[TBL] [Abstract][Full Text] [Related]
10. Single-word comprehension deficits in the nonfluent variant of primary progressive aphasia.
Schaeverbeke J; Gabel S; Meersmans K; Bruffaerts R; Liuzzi AG; Evenepoel C; Dries E; Van Bouwel K; Sieben A; Pijnenburg Y; Peeters R; Bormans G; Van Laere K; Koole M; Dupont P; Vandenberghe R
Alzheimers Res Ther; 2018 Jul; 10(1):68. PubMed ID: 30021613
[TBL] [Abstract][Full Text] [Related]
11. Symptomatology in 4-repeat tauopathies is associated with data-driven topology of [
Schönecker S; Palleis C; Franzmeier N; Katzdobler S; Ferschmann C; Schuster S; Finze A; Scheifele M; Prix C; Fietzek U; Weidinger E; Nübling G; Vöglein J; Patt M; Barthel H; Sabri O; Danek A; Höglinger GU; Brendel M; Levin J;
Neuroimage Clin; 2023; 38():103402. PubMed ID: 37087820
[TBL] [Abstract][Full Text] [Related]
12. Neuroinflammation predicts disease progression in progressive supranuclear palsy.
Malpetti M; Passamonti L; Jones PS; Street D; Rittman T; Fryer TD; Hong YT; Vàsquez Rodriguez P; Bevan-Jones WR; Aigbirhio FI; O'Brien JT; Rowe JB
J Neurol Neurosurg Psychiatry; 2021 Jul; 92(7):769-775. PubMed ID: 33731439
[TBL] [Abstract][Full Text] [Related]
13. Clinical application of MAO-B PET using
Ishibashi K
Geriatr Gerontol Int; 2024 Mar; 24 Suppl 1():31-43. PubMed ID: 37973072
[TBL] [Abstract][Full Text] [Related]
14. Uncovering distinct progression patterns of tau deposition in progressive supranuclear palsy using [
Hong J; Lu J; Liu F; Wang M; Li X; Clement C; Lopes L; Brendel M; Rominger A; Yen TC; Guan Y; Tian M; Wang J; Zuo C; Shi K;
EBioMedicine; 2023 Nov; 97():104835. PubMed ID: 37839135
[TBL] [Abstract][Full Text] [Related]
15. An autopsy case of progressive supranuclear palsy treated with monoclonal antibody against tau.
Beck G; Yamashita R; Kido K; Ikenaka K; Chiba T; Yonenobu Y; Saito Y; Morii E; Hasegawa M; Murayama S; Mochizuki H
Neuropathology; 2023 Aug; 43(4):326-332. PubMed ID: 36593715
[TBL] [Abstract][Full Text] [Related]
16. Complementary Utility of Dopamine Transporter and Tau PET Imaging in the Diagnosis of Progressive Supranuclear Palsy: A Case Report.
Jia C; Wu M; Yen TC; Li Y; Cui R
Clin Nucl Med; 2022 Apr; 47(4):336-338. PubMed ID: 35020665
[TBL] [Abstract][Full Text] [Related]
17. Head-to-Head Comparison of the Two MAO-B Radioligands, 18F-THK5351 and 11C-L-Deprenyl, to Visualize Astrogliosis in Patients With Neurological Disorders.
Ishibashi K; Kameyama M; Miura Y; Toyohara J; Ishii K
Clin Nucl Med; 2021 Jan; 46(1):e31-e33. PubMed ID: 32657879
[TBL] [Abstract][Full Text] [Related]
18. Additive value of [
Katzdobler S; Nitschmann A; Barthel H; Bischof G; Beyer L; Marek K; Song M; Wagemann O; Palleis C; Weidinger E; Nack A; Fietzek U; Kurz C; Häckert J; Stapf T; Ferschmann C; Scheifele M; Eckenweber F; Biechele G; Franzmeier N; Dewenter A; Schönecker S; Saur D; Schroeter ML; Rumpf JJ; Rullmann M; Schildan A; Patt M; Stephens AW; van Eimeren T; Neumaier B; Drzezga A; Danek A; Classen J; Bürger K; Janowitz D; Rauchmann BS; Stöcklein S; Perneczky R; Schöberl F; Zwergal A; Höglinger GU; Bartenstein P; Villemagne V; Seibyl J; Sabri O; Levin J; Brendel M;
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):423-434. PubMed ID: 36102964
[TBL] [Abstract][Full Text] [Related]
19. Direct comparison between
Satoh R; Ali F; Botha H; Lowe VJ; Josephs KA; Whitwell JL
Neuroimage; 2024 Feb; 286():120509. PubMed ID: 38184157
[TBL] [Abstract][Full Text] [Related]
20. Increased Uptake of 18F-THK5351 in Glioblastoma But Not in Primary Central Nervous System Lymphoma.
Mitamura K; Norikane T; Yamamoto Y; Miyake K; Nishiyama Y
Clin Nucl Med; 2021 Sep; 46(9):772-773. PubMed ID: 34028419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
